World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
41654
World Ranking
7323
National Ranking
3833

Yoshifumi Naka publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yoshifumi Naka sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,143 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yoshifumi Naka D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshifumi Naka sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yoshifumi Naka is affiliated with Columbia University in the United States and has a research portfolio primarily focused on fields within medicine and engineering. Their work spans several subfields including surgery, biomedical engineering, cardiology and cardiovascular medicine, emergency medicine, and epidemiology.

The main topics of Yoshifumi Naka's research include mechanical circulatory support devices, cardiac structural anomalies and repair, transplantation methods and outcomes, cardiac arrest and resuscitation, heart failure treatment and management, renal transplantation outcomes and treatments, and congenital heart disease studies.

Frequent co-authors collaborating with Yoshifumi Naka include:

  • Koji Takeda
  • Nir Uriel
  • Gabriel Sayer
  • M. Yuzefpolskaya
  • P.C. Colombo

Key publication venues in which Yoshifumi Naka has extensively contributed are:

  • The Journal of Heart and Lung Transplantation
  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Clinical Transplantation
  • ASAIO Journal

Notable recent papers authored or co-authored by Yoshifumi Naka include:

  • Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial, 2022, JAMA
  • Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association, 2021, Circulation
  • Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019, 2020, JAMA Cardiology
  • Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants, 2021, European Journal of Heart Failure
  • Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent, 2020, JAMA Cardiology

Best Publications

  • Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

    Leslie W. Miller;Leslie W. Miller;Francis D. Pagani;Stuart D. Russell;Ranjit John

  • A fully magnetically levitated left ventricular assist device - Final report

    Mandeep R. Mehra;Nir Uriel;Yoshifumi Naka;Joseph C. Cleveland

  • Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

    Francis D. Pagani;Leslie W. Miller;Stuart D. Russell;Keith D. Aaronson

  • Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection

    Katherine Lietz;Katherine Lietz;Katherine Lietz;James W. Long;Abdallah G. Kfoury;Mark S. Slaughter

  • Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of Transplantation

    Nir Uriel;Sang Woo Pak;Ulrich P. Jorde;Brigitte Jude

  • Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.

    E. S. Connolly;C. J. Winfree;T. A. Springer;Y. Naka

  • A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure

    Mandeep R. Mehra;Yoshifumi Naka;Nir Uriel;Daniel J. Goldstein

  • Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

    Mandeep R. Mehra;Daniel J. Goldstein;Nir Uriel;Joseph C. Cleveland

  • Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.

    Shi Fang Yan;Ravichandran Ramasamy;Yoshifumi Naka;Ann Marie Schmidt

  • Right Heart Failure After Left Ventricular Assist Device Implantation in Patients With Chronic Congestive Heart Failure

    Nicholas C. Dang;Veli K. Topkara;Michelle Mercando;Joy Kay

  • Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation: A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)

    Randall C. Starling;Yoshifumi Naka;Andrew J. Boyle;Gonzalo Gonzalez-Stawinski

  • Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis.

    Tomoyuki Fujita;Koichi Toda;Ann Karimova;Shi-Fang Yan

  • Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial

    Abbas Ardehali;Fardad Esmailian;Mario Deng;Edward Soltesz

  • Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

    Nir Uriel;Kerry A. Morrison;Arthur R. Garan;Tomoko S. Kato

  • Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem.

    Minoo N Kavarana;Melissa S Pessin-Minsley;Jacqueline Urtecho;Katharine A Catanese

  • Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.

    David J. Pinsky;Yoshifumi Naka;Hui Liao;Mehmet C. Oz

  • Central role of RAGE-dependent neointimal expansion in arterial restenosis

    Taichi Sakaguchi;Shi Fang Yan;Shi Du Yan;Dmitri Belov

  • Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure

    Aalap Chokshi;Konstantinos Drosatos;Faisal H. Cheema;Ruiping Ji

  • Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: A prospective study using the INTERMACS registry (interagency registry for mechanically assisted circulatory support)

    Ulrich P. Jorde;Sudhir S. Kushwaha;Antone J. Tatooles;Yoshifumi Naka

  • Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices

    Sang Woo Pak;Nir Uriel;Hiroo Takayama;Sarah Cappleman

Frequent Co-Authors

Donna Mancini
Donna Mancini Icahn School of Medicine at Mount Sinai
Mehmet C. Oz
Mehmet C. Oz Columbia University
David J. Pinsky
David J. Pinsky University of Michigan–Ann Arbor
Ranjit John
Ranjit John University of Minnesota
Mathew R. Williams
Mathew R. Williams New York University
Eric A. Rose
Eric A. Rose Icahn School of Medicine at Mount Sinai
Francis D. Pagani
Francis D. Pagani University of Michigan–Ann Arbor
Carmelo A. Milano
Carmelo A. Milano Duke University
Ajay J. Kirtane
Ajay J. Kirtane Columbia University
Shi Fang Yan
Shi Fang Yan Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn't limited to becoming a doctor. There are flexible and accessible online programs that offer valuable healthcare qualifications—ideal for those looking to start or advance their health-related careers.

Medical billing and coding is a high-demand field, and you can now find financial aid for medical billing and coding online classes, making it easier to start with minimal upfront costs.

Those interested in patient care might consider nursing as a pathway. Some institutions offer nursing school no entrance exam required—helpful if standardized testing is a barrier for you.

For those aiming for leadership, an online healthcare administration degree lets you build management expertise from wherever you are.

Nurses seeking to advance can find adn to fnp programs online, offering a fast-track from an associate in nursing to a family nurse practitioner role.

These pathways provide alternative routes into healthcare, each with unique benefits, flexible study options, and diverse career outcomes.

Best Scientists Citing Yoshifumi Naka

Trending Scientists

Recently Published Articles